​

Funding Round

Post-IPO Debt - VectivBio

Post-IPO Debt - VectivBio

Investment Firm

Overview

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

Announced Date

Mar 30, 2022

Funding Type

Post Ipo Debt

Highlights

Location

Switzerland, Europe

Social

Investor Lead

Kreos Capital

Kreos Capital

Kreos Capital is a debt and early_stage_venture and late_stage_venture and private_equity firm.

Participant Investors

1

Investor Name
Participant InvestorKreos Capital

Round Details and Background

VectivBio raised $75000000 on 2022-03-30 in Post-IPO Debt

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 19, 2020
Venture Round - VectivBio
10-110.0M
Mar 30, 2022
Post-IPO Debt - VectivBio
1-75.0M
Jun 29, 2022
Post-IPO Equity - VectivBio
1-54.0M
Oct 13, 2022
Post-IPO Equity - VectivBio
11-125.0M

Recent Activity

There is no recent news or activity for this profile.